发布时间:2019-08-02 23:22 原文链接: HumanFastTrackmRNAIsolation

Preparation of Cells

1.Prepare or collect between 2x107 cells for each mRNA prep (will yield about 10-20µg of mRNA). If PBMCs from a whole blood sample are to be used, the sample should be prepared with Ficoll-Paque according to the manufacturer's protocol. The isolated PBMCs can then be used in this protocol.

2.If cells are adherent, gently agitate and scrape cells from the surface of the flask with a cell scraper to suspend in the media. If cells are non-adherent, proceed to next step.

3.Place the suspension of cells in a 50ml conical tube, pellet at ~400xg for 5 minutes.

4.Discard the supernatant, leave the pellet intact.

5.Freeze the pellet in a dry ice/ethanol bath (or on liquid N2) until solid.

6.Store at -70℃ until ready for mRNA preparation.

Modified FastTrack 2.0 Protocol

Isolation of mRNA

1.Add 15ml of Lysis Buffer (15ml Stock Buffer + 300 ul RNase/Protein Degrader) to the frozen pellet.

2.The tissue homogenizer should be cleaned so that it is RNase-free. At a minimum will require immersion and homogenization in ddH2 O and ethanol 3 times sequentially, may require boiling H2 O, SDS, or 10% bleach in addition. An RNAse degrader such as RNAse Zap can also be used.

3.Shear each sample with a 3-5 second run of the tissue homogenizer, essentially until the cell pellet is no longer visible. Clean homogenizer tip between runs.

4.Incubate the sheared samples in Lysis Buffer at 45℃ for 45 minutes.

5.Add 950 µl 5M NaCl stock solution and mix.

6.Shear DNA using a 21 gauge needle attached to a sterile 20cc syringe. This step involves drawing the lysate into the syringe through the needle and expelling it from the syringe, again through the needle. This step should be repeated 3 times.

7.Add one tube of oligo(dT) cellulose to each sample.

8.Incubate for 2 minutes at room temperature. Vortex the sample to resuspend the cellulose completely.

9.Rock the tube gently in a horizontal position for 60-90 minutes at room temperature.

10.Centrifuge the oligo(dT) slurry at 3,000 x g for 5 minutes at room temperature. Make sure the brake on the centrifuge is set at low for all centrifugation steps, as a high brake may disturb the pellet.

11.Carefully aspirate and discard the supernatant, trying not to disturb the easily dispersed pellet.

Washing Oligo(dT) Cellulose

1.Resuspend oligo(dT) in 20ml Binding Buffer by vortexing.

2.Centrifuge at 3,000 x g for 5 minutes at room temperature.

3.Resuspend oligo(dT) in 10ml Binding Buffer by vortexing.

4.Centrifuge at 3,000 x g for 5 minutes at room temperature.

5.Resuspend oligo(dT) in 10ml Low Salt Wash Buffer by vortexing.

6.Centrifuge at 3,000 x g for 5 minutes at room temperature.

7.Repeat Low Salt Wash Buffer wash two more times.

8.Resuspend oligo(dT) in 800µl Low Salt Wash Buffer using a 1-2ml serological pipette.

9.Transfer about 800µl of the oligo(dT) slurry to a spin column seated in the included microcentrifuge tube.

101Centrifuge at 5,000 x g for 10 seconds at room temperature.

11.Aspirate and discard the flow-through liquid in the microcentrifuge tube.

12.Repeat the transfer and centrifugation steps until ALL of the oligo(dT) cellulose is in the spin column.

Elution and Precipitation of the mRNA

1.Place the spin column containing the oligo(dT) into one of the included clean microcentrifuge tubes.

2.Heat elution buffer to 65℃ in a bath (or about 10-15 seconds in a microwave).

3.Resuspend the oligo(dT) in 200µl Elution Buffer (heated), using the pipette tip to gently swirl the cellulose, without puncturing the underlying spin column membrane.

4.Centrifuge at 5,000 x g for 30 seconds at room temperature. Do not decant. Keep the eluent, it contains your mRNA.

5.Again resuspend the oligo(dT) in 200µl Elution Buffer (heated).

6.Centrifuge at 5,000 x g for 30 seconds at room temperature.

7.Save the combined 400µl eluent in the microcentrifuge tube.

8.Add 60µl of 2M sodium acetate and mix.

9.Add 1ml of 95% ethanol (Do not use 100% ethanol, it contains fluorescent contaminants).

10.Freeze at -70℃ overnight.

11.Thaw and centrifuge at 16,000 x g for 15 minutes at 4℃.

12.Carefully aspirate all the ethanol from the mRNA pellet, taking care not to disturb the pellet.

13.Resuspend the mRNA pellet in 20µl of Elution Buffer (heated as before).

14.Determine the concentration of the mRNA by OD or "eyeballing" on an agarose minigel.

15.Store mRNA at -70℃.

16.The standard FastTrack protocol can be found on the Invitrogen website here.


相关文章

科学家实现mRNA体内精准靶向递送

近日,中国科学院国家纳米科学中心成功创建了一种基于脂质空间构象的人工智能(AI)全新模型,通过精准解析可电离脂质的三维空间构象,成功攻克了脂质纳米颗粒(LNP)在mRNA药物递送中存在的转染效率低下与......

mRNA疫苗递送研究取得进展

mRNA疫苗进入人体后极易被降解,因此必须借助脂质纳米颗粒(LNP)作为“运输工具”。但传统LNP存在一些问题:一方面,它们在体内的真实去向并不清楚;另一方面,大量载体会被肝脏“误捕获”,既降低了靶组......

mRNA“戴帽”后能多产两百倍蛋白质

日本名古屋大学研究团队在最新一期《自然·生物技术》杂志上发表了一项名为“内部帽启动翻译”(ICIT)机制的创新研究。该机制下的仿佛戴着帽子的mRNA可产生200倍以上的蛋白质,为治疗癌症和蛋白质合成异......

科研人员开发出高效植物mRNA递送系统

基因组编辑技术在农业领域的应用推动了作物改良,但以DNA形式递送基因编辑工具的方式存在外源DNA整合风险和脱靶效应。近年来,无外源DNA残留的基因组编辑递送技术备受关注。尽管基于核糖核蛋白的递送策略在......

mRNA技术有望治疗先兆子痫

一种mRNA疗法在小鼠身上的成功试验,为治疗常见妊娠并发症——先兆子痫带来希望。近日,相关论文发表于《自然》。高血压是子痫前期的常见症状。图片来源:NataliyaPiatrovich/Alamy在可......

GSK公司|季节性流感mRNA疫苗2期临床试验结果积极

2024年4月,葛兰素史克(GSK)在一项2期临床试验中证实,其候选mRNA流感疫苗在预防甲型流感方面战胜了已获批的灭活流感疫苗,但对于“历史性难题”乙型流感方面未能达到同样的效果。与GSK合作研发该......

定制mRNA载体可快速创建并自带“导航”

7月11日,美国宾夕法尼亚大学研究团队利用“点击化学”技术,通过一个简单步骤创建出脂质纳米颗粒(LNP)。发表在最新一期《自然·化学》杂志上的这项研究表明,其不仅加快了合成过程,还提供了一种为这些输送......

定制mRNA载体可快速创建并自带“导航”

脂质纳米颗粒是最先进的药物输送平台之一,可以运送mRNA。图片来源:penntoday网站科技日报北京7月11日电(记者张梦然)美国宾夕法尼亚大学研究团队利用“点击化学”技术,通过一个简单步骤创建出脂......

Nature子刊:刘帅/顾臻/平渊团队设计三组分LNP,实现器官靶向的mRNA积累和翻译

mRNA疗法在治疗多种蛋白质相关疾病方面已展现出巨大潜力,其潜在应用与靶向给药技术的进步密切相关。真正的靶向需要在特定器官中同时发生mRNA的积累和翻译,以实现治疗功能并将副作用降至最低.然而,现有的......

2024年,西湖大学施一公团队合作再取进展

U2小核核糖核蛋白(snRNP)对pre-mRNA分支位点(BS)的选择对于剪接前体(Acomplex)的组装至关重要。RNA解旋酶PRP5校对BS选择,但其潜在机制尚不清楚。2024年1月9日,西湖......